Herbs (Global Traditional) · Traditional Chinese Medicine
Siberian Ginseng (Eleutherococcus senticosus) (Eleutherococcus senticosus)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Siberian Ginseng, or Eleutherococcus senticosus, is an adaptogenic herb containing eleutherosides, which modulate the body's physiological response to stress. It supports overall resilience by influencing adrenal function and neurotransmitter balance.
Siberian Ginseng (Eleutherococcus senticosus) is a perennial shrub native to Northern Asia, particularly Russia, China, and Korea, where its roots and rhizomes are harvested for medicinal use. The extract is typically obtained from dried roots via solvent extraction using water, ethanol, or ethyl acetate, yielding a complex mixture of lignan glycosides (eleutherosides), phenylpropanoids, coumarins, and triterpenoid saponins.
The research dossier reveals a significant gap in clinical evidence - no specific human RCTs, meta-analyses, or PubMed PMIDs are detailed for E. senticosus. While general references note positive preclinical outcomes and in vitro receptor binding studies, human clinical trial data including study designs, sample sizes, and quantified outcomes are absent from the available research.
No clinically studied dosage ranges, standardized forms, or eleutheroside content specifications are provided in the available research. Traditional use implies root extracts, but quantified human dosing from clinical trials is absent. Consult a healthcare provider before starting any new supplement.
Siberian Ginseng (Eleutherococcus senticosus) is not consumed as a macronutrient source; its value lies entirely in its bioactive phytochemical profile. Key compounds include: **Eleutherosides (A–M):** The principal active constituents, found primarily in the root and rhizome at approximately 0.6–0.9% total eleutheroside content (dried root basis). Eleutheroside B (syringin, a phenylpropanoid glycoside) is typically present at ~0.1–0.2% and is a primary marker compound used for standardization. Eleutheroside E (a lignan glycoside, specifically syringaresinol diglucoside) is present at ~0.03–0.08% and is the second key marker. Other eleutherosides include Eleutheroside A (daucosterol, a sterol glycoside), Eleutheroside C (a coumarin glycoside), and Eleutheroside D (a lignan glycoside). **Polysaccharides:** Water-soluble heteroglycans account for approximately 2–8% of dried root weight; these are primarily responsible for immunomodulatory activity and include glucans and arabinogalactans. **Phenolic compounds:** Including chlorogenic acid (~0.02–0.05%), caffeic acid derivatives, and various phenylpropanoids contributing to antioxidant capacity. **Lignans:** Beyond Eleutheroside E, sesamin and related lignans are present in trace amounts. **Triterpenoid saponins:** Including oleanolic acid-based saponins in small quantities (~0.1–0.3%). **Sterols:** Beta-sitosterol and daucosterol present at trace to minor levels. **Vitamins and minerals:** Not a significant dietary source; trace amounts of vitamin A precursors, vitamin C, and B-vitamins have been reported but are nutritionally negligible at typical dosing (300–1200 mg dried root extract per day). Mineral content includes trace iron, manganese, and zinc in the whole root but again negligible at therapeutic doses. **Fiber:** The crude root contains ~15–25% dietary fiber, but this is largely irrelevant in extract form. **Protein:** Approximately 5–8% crude protein in dried root; negligible in standardized extracts. **Bioavailability notes:** Eleutheroside B (syringin) demonstrates moderate oral bioavailability (~20–40% estimated from rodent pharmacokinetic studies), with rapid absorption (Tmax ~30–60 minutes) and hepatic metabolism to sinapyl alcohol. Eleutheroside E shows lower oral bioavailability (~10–20%) due to molecular weight and glycoside hydrolysis in the gut. Polysaccharides are not absorbed intact but exert immunomodulatory effects via gut-associated lymphoid tissue (GALT) and Peyer's patches. Standardized extracts are typically normalized to ≥0.8% Eleutheroside B + Eleutheroside E combined. Note: Eleutherosides are structurally unrelated to ginsenosides found in Panax ginseng despite the common name 'Siberian Ginseng.'
Eleutherosides, particularly eleutheroside B and E, are the primary active compounds in Siberian Ginseng. These compounds are believed to modulate the hypothalamic-pituitary-adrenal (HPA) axis, enhancing the body's ability to adapt to physical and mental stressors. They may also influence neurotransmitter systems and cellular energy metabolism.
Clinical research on Siberian Ginseng, though promising, often involves small sample sizes or uses proprietary extracts, making generalizations challenging. Some human studies suggest benefits in reducing fatigue and improving endurance, with doses around 300-400 mg of standardized extract daily over 6-8 weeks. However, robust, large-scale randomized controlled trials are needed to definitively confirm its adaptogenic, performance-enhancing, and immune-modulating effects observed in traditional use and preclinical models. Evidence for its use in chronic stress conditions is primarily based on traditional medicine practices.
Siberian Ginseng is generally well-tolerated, with mild side effects like insomnia, irritability, or diarrhea reported occasionally. It may interact with medications such as anticoagulants due to potential platelet aggregation inhibition, and possibly alter blood sugar levels, requiring caution in diabetics. Individuals with high blood pressure, sleep disorders, or during pregnancy and breastfeeding should consult a healthcare professional before use, as insufficient safety data exists for these populations. It is contraindicated in acute infectious diseases and severe hypertension.
